SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-007543
Filing Date
2024-03-13
Accepted
2024-03-13 08:02:13
Documents
16
Period of Report
2024-03-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20231022_8k.htm   iXBRL 8-K 29143
2 EXHIBIT 99.1 ex_584126.htm EX-99.1 144883
  Complete submission text file 0001437749-24-007543.txt   339946

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA clnn-20240313.xsd EX-101.SCH 3943
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20240313_def.xml EX-101.DEF 13521
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20240313_lab.xml EX-101.LAB 17826
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20240313_pre.xml EX-101.PRE 13498
17 EXTRACTED XBRL INSTANCE DOCUMENT clnn20231022_8k_htm.xml XML 4957
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 852828339 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 24744618
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)